Ryvu Therapeutics SA engages in the provision of products and solutions for the pharmaceutical and biotechnology industry. Its projects and services include contract chemistry services, biology services, integrated drug discovery, and comparative studies of biosimilar medicinal products. The company was founded by Boguslaw Sieczkowski and Pawel Przewiezlikowski in 2007 and is headquartered in Krakow, Poland.